Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance.

[1]  Carola Berking,et al.  Melanoma , 2018, The Lancet.

[2]  A. Ribas,et al.  Targeted Therapy for Melanoma. , 2016, Cancer treatment and research.

[3]  G. Kaushik,et al.  Honokiol inhibits melanoma stem cells by targeting notch signaling , 2015, Molecular carcinogenesis.

[4]  B. Su,et al.  MDA-9 and GRP78 as potential diagnostic biomarkers for early detection of melanoma metastasis , 2015, Tumor Biology.

[5]  G. Kaushik,et al.  Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway. , 2014, American journal of surgery.

[6]  J. Bussink,et al.  The unfolded protein response as a target for cancer therapy. , 2014, Biochimica et biophysica acta.

[7]  P. Abbe,et al.  Preview : Published ahead of advance online publication Inhibition of Melanogenesis by the Antidiabetic Metformin , 2014 .

[8]  A. Eggermont,et al.  eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies , 2014, Nature.

[9]  A. Eggermont,et al.  Cutaneous melanoma , 2014, The Lancet.

[10]  M. Herlyn,et al.  Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma. , 2014, The Journal of clinical investigation.

[11]  S. Shenolikar.  Dangerous liaisons: flirtations between oncogenic BRAF and GRP78 in drug-resistant melanomas. , 2014, The Journal of clinical investigation.

[12]  G. Garçon,et al.  Mitochondrial oxidative stress is the achille's heel of melanoma cells resistant to Braf-mutant inhibitor , 2013, Oncotarget.

[13]  B. Lefkove,et al.  Inducing apoptosis of cancer cells using small-molecule plant compounds that bind to GRP78 , 2013, British Journal of Cancer.

[14]  P. Abbe,et al.  Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner , 2013, Molecular Cancer Therapeutics.

[15]  C. Goding.  The path of least resistance: enhancing the effectiveness of BRAF inhibitors , 2013, Pigment cell & melanoma research.

[16]  P. Lambin,et al.  PERK/eIF2α signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS , 2013, Proceedings of the National Academy of Sciences.

[17]  Afshin Samali,et al.  New directions in ER stress-induced cell death , 2013, Apoptosis.

[18]  D. Maddalo,et al.  The Molecular Chaperone GRP78/BiP in the Development of Chemoresistance: Mechanism and Possible Treatment , 2013, Front. Pharmacol..

[19]  K. Flaherty,et al.  Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. , 2012, The New England journal of medicine.

[20]  Zongwei Li,et al.  Glucose regulated protein 78: a critical link between tumor microenvironment and cancer hallmarks. , 2012, Biochimica et biophysica acta.

[21]  R. Zeiser,et al.  Immunotherapy for Malignant Melanoma Robert , 2012 .

[22]  Robert Clarke,et al.  Guidelines for the use and interpretation of assays for monitoring autophagy , 2012 .

[23]  R. Zeiser,et al.  Immunotherapy for malignant melanoma. , 2012, Current stem cell research & therapy.

[24]  S. Shankar,et al.  Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. , 2011, Biochemical pharmacology.

[25]  P. Bahadoran,et al.  Metformin inhibits melanoma development through autophagy and apoptosis mechanisms , 2011, Cell Death and Disease.

[26]  A. Aplin,et al.  Mechanisms of resistance to RAF inhibitors in melanoma , 2011, The Journal of investigative dermatology.

[27]  J. Ortonne,et al.  Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth , 2011, Cell Death and Differentiation.

[28]  K. Flaherty,et al.  Inhibition of mutated, activated BRAF in metastatic melanoma. , 2010, The New England journal of medicine.

[29]  Shing-Hwa Liu,et al.  Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress. , 2010, Cancer letters.

[30]  Philippe Lambin,et al.  The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. , 2010, The Journal of clinical investigation.

[31]  K. Smalley.  Understanding melanoma signaling networks as the basis for molecular targeted therapy. , 2010, The Journal of investigative dermatology.

[32]  E. Morselli,et al.  Anti- and pro-tumor functions of autophagy. , 2009, Biochimica et biophysica acta.

[33]  P. Bahadoran,et al.  In vitro and in vivo anti-melanoma effects of ciglitazone. , 2009, The Journal of investigative dermatology.

[34]  R. Scolyer,et al.  Expression of glucose‐regulated stress protein GRP78 is related to progression of melanoma , 2009, Histopathology.

[35]  P. Codogno,et al.  Does autophagy have a license to kill mammalian cells? , 2009, Cell Death and Differentiation.

[36]  F. Rizzi,et al.  Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[37]  G. Shore,et al.  The endoplasmic reticulum in apoptosis and autophagy: role of the BCL-2 protein family , 2008, Oncogene.

[38]  H. Mukhtar,et al.  Multitargeted therapy of cancer by green tea polyphenols. , 2008, Cancer letters.

[39]  M. Jäättelä,et al.  Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium , 2007, Cell Death and Differentiation.

[40]  Amy S. Lee.  GRP78 induction in cancer: therapeutic and prognostic implications. , 2007, Cancer research.

[41]  Afshin Samali,et al.  Mediators of endoplasmic reticulum stress‐induced apoptosis , 2006, EMBO reports.

[42]  M. Demierre.  Epidemiology and prevention of cutaneous melanoma , 2006, Current treatment options in oncology.

[43]  P. Codogno,et al.  Regulation and role of autophagy in mammalian cells. , 2004, The international journal of biochemistry & cell biology.

[44]  I. Braakman,et al.  Quality control in the endoplasmic reticulum protein factory , 2003, Nature.

[45]  Ari Helenius,et al.  Quality control in the endoplasmic reticulum , 2003, Nature Reviews Molecular Cell Biology.

[46]  J Auwerx,et al.  PPARgamma, the ultimate thrifty gene. , 1999, Diabetologia.